Study shows distancing and mandatory masks can forestall 87% of grounds COVID-19 diseases Kumar Jeetendra | January 13, 2021 The combined effectiveness of three COVID-prevention strategies on college campuses–mask-wearing, social distancing, and routine testing–are equally as effective in preventing coronavirus infections as the Pfizer and Moderna vaccines approved by the U.S. Food and Drug Administration (FDA), according to a new study co-authored by a Case Western Reserve University researcher. The study, published in Annals …
Genomic surveillance can help recognize how SARS-CoV-2 spreads in care homes Kumar Jeetendra | March 4, 2021 Care homes are at high risk of experiencing outbreaks of COVID-19, the disease brought on by SARS-CoV-2. Older people and people affected by heart disease, respiratory disease and type 2 diabetes – all of which increase with age – are at greatest risk of severe disease and even death, which makes the care home population …
Study shows the effect of ‘reverse antibiotic’ on gram-negative bacteria Kumar Jeetendra | March 5, 2021 Researchers from Skoltech and MSU have investigated antibiotic nybomycin that could prove effective against bacteria resistant to other antibiotics. Their research was published in the journal Antimicrobial Agents and Chemotherapy. All bacterial cells contain topoisomerases, a significant group of enzymes that help deal with spatial problems stemming from bacterial cell division related to circular DNA …
FDA issues emergency use approval for T-Detect COVID Test Kumar Jeetendra | March 7, 2021 Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for its T-Detect COVID Exam developed by Adaptive Biotechnologies. The T-Detect COVID Evaluation is a next generation sequencing established (NGS) test to assist in identifying people with an adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with SARS-CoV-2. …
UMass Amherst scientist focuses around understanding essential parts of the hand’s microbiome Kumar Jeetendra | March 14, 2021 Skin Care microbiome researcher Dr. Kelly Haas, of the University of Massachusetts Amherst’s Biology Department, recently started a research partnership with Akron, Ohio-based GOJO Industries to study the structure, stability, and endurance of their hand microbiome. The collaboration focuses on understanding fundamental aspects of the hand’s microbiome: what microbes should be growing on a hand …
FDA approves first AI based COVID-19 non-diagnostic screening Kumar Jeetendra | March 21, 2021 Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic testing apparatus that identifies certain biomarkers that are indicative of some kinds of conditions, such as hypercoagulation (a condition causing blood to clot more readily than normal). The Tiger Tech COVID Plus …
Scientists use genetics to recognize likely drugs for early administration of COVID-19 Kumar Jeetendra | April 12, 2021 A new study using human genetics indicates researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. The findings appeared online in the journal Nature Medicine at March 2021. The purpose is to identify present drugs, either FDA-approved or in clinical development for other conditions, that can …
Critical care attendants in poor physical and mental wellness report more medical errors Kumar Jeetendra | May 4, 2021 A study led by The Ohio State University College of Nursing finds that critical care nurses in poor physical and mental health reported significantly more medical errors than nurses in better health. The analysis, which was conducted prior to the COVID-19 pandemic, also found that”nurses who perceived their worksite was very supportive of the well-being …
Genomic study tracks the rise of multidrug resistant E.coli Kumar Jeetendra | May 17, 2021 Antibiotic resistance in E.coli has been steadily rising since the early 2000s despite attempts to control it, a new study suggests. In the biggest genomic survey of E.coli to date, that took more than 16 years in Norway, researchers have successfully tracked the spread of antibiotic resistant genes and have demonstrated that these genes are …
Vasu Healthcare takes several initiatives to support its employees during Covid Kumar Jeetendra | May 20, 2021 20 May 2021: Vadodara based Vasu Healthcare Pvt Ltd – a leading company in herbal and ayurveda space has taken several initiatives to support its employees and their families in battling Covid-19. Company has taken measures including special paid leaves, reimbursements of medical tests, financial support, testing & hospitalisation for the needy employees among others. …
Indica Labs and Ibex Partner to Deliver AI-powered Clinical Workflows for Digital Pathology Kumar Jeetendra | May 20, 2021 ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Life Science Newswire – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO …
Growing genomic research into different ancestries yields more and better outcomes Kumar Jeetendra | June 1, 2021 Currently published in Nature Genetics, their findings demonstrate that expanding research into different ancestries yields more and better results, in addition to ultimately benefitting global patient care. Up to now nearly 87 percent of genomic research of the type was conducted in Europeans. The global study team examined data across a wide assortment of cohorts, …
